Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects
•The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter binding.•5mC and 5hmC levels in the promoters do not account for the increased binding. These data and a study on the cerebella from the same ASD coho...
Saved in:
Published in | International journal of developmental neuroscience Vol. 62; no. 1; pp. 63 - 72 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Ltd
01.11.2017
Elsevier BV |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter binding.•5mC and 5hmC levels in the promoters do not account for the increased binding. These data and a study on the cerebella from the same ASD cohort are discussed.
Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains.
We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP).
We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments.
Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed. |
---|---|
AbstractList | Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down‐regulation of genes expressed in GABAergic neurons in ASD brains.
We measured mRNA levels corresponding to selected GABAergic genes using qRT‐PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5‐methylcytosine (5mC) and 5‐hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP).
We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten‐eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments.
Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down‐regulated in post‐mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed. Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there was decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed. Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed.Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed. Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed. •The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter binding.•5mC and 5hmC levels in the promoters do not account for the increased binding. These data and a study on the cerebella from the same ASD cohort are discussed. Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously shown that both mRNAs are reduced in the cerebella (CB) of ASD subjects through a mechanism that involves increases in the amounts of MECP2 binding to the corresponding promoters. In the current study, we examined the expression of RELN, GAD1, GAD2, and several other mRNAs implicated in this disorder in the frontal cortices (FC) of ASD and CON subjects. We also focused on the role that epigenetic processes play in the regulation of these genes in ASD brain. Our goal is to better understand the molecular basis for the down-regulation of genes expressed in GABAergic neurons in ASD brains. We measured mRNA levels corresponding to selected GABAergic genes using qRT-PCR in RNA isolated from both ASD and CON groups. We determined the extent of binding of MECP2 and DNMT1 repressor proteins by chromatin immunoprecipitation (ChIP) assays. The amount of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) present in the promoters of the target genes was quantified by methyl DNA immunoprecipitation (MeDIP) and hydroxyl MeDIP (hMeDIP). We detected significant reductions in the mRNAs associated with RELN and GAD1 and significant increases in mRNAs encoding the Ten-eleven Translocation (TET) enzymes 1, 2, and 3. We also detected increased MECP2 and DNMT1 binding to the corresponding promoter regions of GAD1, RELN, and GAD2. Interestingly, there were decreased amounts of 5mC at both promoters and little change in 5hmC content in these same DNA fragments. Our data demonstrate that RELN, GAD1, and several other genes selectively expressed in GABAergic neurons, are down-regulated in post-mortem ASD FC. In addition, we observed increased DNMT1 and MECP2 binding at the corresponding promoters of these genes. The finding of increased MECP2 binding to the RELN, GAD1 and GAD2 promoters, with reduced amounts of 5mC and unchanged amounts of 5hmC present in these regions, suggests the possibility that DNMT1 interacts with and alters MECP2 binding properties to selected promoters. Comparisons between data obtained from the FC with CB studies showed some common themes between brain regions which are discussed. |
Author | Guidotti, Alessandro Zhubi, Adrian Grayson, Dennis R. Chen, Ying |
AuthorAffiliation | 4 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. dgrayson@psych.uic.edu 2 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Ychen@psych.uic.edu 3 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Aguidotti@psych.uic.edu 1 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Adrian.Zhubi@osfhealthcare.org |
AuthorAffiliation_xml | – name: 2 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Ychen@psych.uic.edu – name: 1 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Adrian.Zhubi@osfhealthcare.org – name: 4 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. dgrayson@psych.uic.edu – name: 3 The Psychiatric Institute, Center for Alcohol Research in Epigenetics, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, United States. Aguidotti@psych.uic.edu |
Author_xml | – sequence: 1 givenname: Adrian surname: Zhubi fullname: Zhubi, Adrian email: Adrian.Zhubi@osfhealthcare.org – sequence: 2 givenname: Ying surname: Chen fullname: Chen, Ying email: Ychen@psych.uic.edu – sequence: 3 givenname: Alessandro surname: Guidotti fullname: Guidotti, Alessandro email: Aguidotti@psych.uic.edu – sequence: 4 givenname: Dennis R. surname: Grayson fullname: Grayson, Dennis R. email: dgrayson@psych.uic.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28229923$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkVFv0zAUhS00xLrCX5gs8dI9tNhxEqcSQqvabrSqigQM8Wa59k3nKLWLnRT273HoNsFexpMl33OOz_V3hk6ss4DQOSUjSmj-rhqZSsPBQjtKCOUjkowIYS9QjxacDVOefj9BPcJZPsx4WpyisxAqQkiWkfQVOk2KJBmPE9ZD9XxvtmChMQp72La1bIyz2JX483y1xtJqfD2ZUWwsbm4Bl97ZRtZYOd_ALzy4ml50Wtk2Juxw2INqfLvD2gTnNXg8mHyZXeDQbqo4Ca_Ry1LWAd7cn310czX_Ov04XH26Xkwnq6HKaNc-TSWTacF5VoxpqVlZaJ4zXqhCq3wjqdaxe64TnW9ovikV4yonXMoctNacsD76cMzdt5sdaAW28bIWe2920t8JJ434d2LNrdi6g8gyno2LLmBwH-DdjxZCI3YmKKhracG1QcRPplmWsYRF6dsn0sq13sb1BB3nRUpoGmV9dP53o8cqDyCiID8KlHcheCgfJZSIjrioxANx0REXJBGReDS-f2JUpvkDMW5m6ufti6P9p6nh7j8fFcvZerlYzubf1vOb7p4kx6zLYxZEtgcDXgRlwCrQxkf8QjvzXJ3fgIHh0g |
CitedBy_id | crossref_primary_10_1055_s_0041_1735540 crossref_primary_10_51847_DysH69LijA crossref_primary_10_3390_ijms25073881 crossref_primary_10_1016_j_ijdevneu_2019_04_004 crossref_primary_10_3390_biom14040437 crossref_primary_10_2217_epi_2022_0184 crossref_primary_10_1016_j_heliyon_2021_e06105 crossref_primary_10_1016_j_neuroscience_2023_08_028 crossref_primary_10_3390_ph11020056 crossref_primary_10_1016_j_ijdevneu_2017_08_002 crossref_primary_10_3389_fped_2019_00225 crossref_primary_10_1007_s11356_020_09819_5 crossref_primary_10_3389_fnmol_2025_1546083 crossref_primary_10_3390_cells11213439 crossref_primary_10_3390_microorganisms6040107 crossref_primary_10_3389_fncel_2019_00385 crossref_primary_10_12677_ACM_2021_113169 crossref_primary_10_3390_cells13131095 crossref_primary_10_1093_eep_dvae023 crossref_primary_10_2217_epi_2022_0179 crossref_primary_10_1016_j_ebiom_2022_104091 crossref_primary_10_1016_j_mam_2019_07_004 crossref_primary_10_1097_MD_0000000000034420 crossref_primary_10_1016_j_envres_2018_05_020 crossref_primary_10_3389_fncel_2018_00078 crossref_primary_10_1093_ijnp_pyx075 crossref_primary_10_1515_revneuro_2021_0014 crossref_primary_10_1007_s12311_021_01264_5 crossref_primary_10_3389_fneur_2021_612817 crossref_primary_10_3389_fnmol_2023_1275697 crossref_primary_10_1186_s40478_021_01190_x crossref_primary_10_3389_fncel_2024_1499719 crossref_primary_10_3390_cells13242036 crossref_primary_10_1017_pcm_2024_2 crossref_primary_10_1111_pcn_12606 crossref_primary_10_1007_s12272_019_01196_z crossref_primary_10_3390_biom10060964 crossref_primary_10_3390_jcm8122088 crossref_primary_10_1038_s41392_022_01081_0 crossref_primary_10_3390_ijms23169188 crossref_primary_10_3390_ijms24119138 crossref_primary_10_3389_fnmol_2018_00423 crossref_primary_10_1016_j_jpsychires_2021_06_013 crossref_primary_10_1007_s42764_025_00147_x crossref_primary_10_1016_j_fct_2022_113423 crossref_primary_10_3390_ijms23073861 crossref_primary_10_2217_epi_2021_0494 |
Cites_doi | 10.1016/S0006‐3223(02)01430‐0 10.1038/nrn3475 10.1016/B978‐0‐12‐801311‐3.00006‐8 10.1016/j.jpsychires.2011.06.001 10.1093/nar/gkf401 10.1186/1741‐7015‐7‐62 10.1093/nar/gku1305 10.1080/15592294.2015.1114202 10.1016/j.cell.2012.11.022 10.1093/nar/gkw1197 10.1038/nature14319 10.1007/s10803‐006‐0226‐7 10.1001/archpsyc.57.11.1061 10.1038/nrn3956 10.1111/j.1471‐4159.2010.06858.x 10.1038/nature10524 10.1016/j.tins.2005.03.010 10.1038/tp.2016.87 10.1007/s12311‐008‐0075‐3 10.1038/tp.2014.87 10.1007/s10803‐012‐1543‐7 10.1023/A:1013238809666 10.1007/s12035‐015‐9658‐4 10.3389/fnins.2016.00601 10.1007/s00401-006-0176-3 10.1007/s00018-016-2304-0 10.1038/nature10110 10.1038/nature20612 10.1016/j.cell.2015.06.034 10.2478/s13380-011-0016-3 10.1016/j.mehy.2014.04.014 10.1007/s10803‐014‐2078‐x 10.1038/tp.2015.191 10.1073/pnas.1031602100 10.1038/374719a0 10.1038/nrn.2016.41 10.2217/epi.15.92 10.1016/j.neuropharm.2012.04.013 10.1038/ncomms6748 10.1073/pnas.95.26.15718 10.1086/433195 10.1002/ajmg.b.31148 10.1007/s10803‐009‐0924‐z 10.1038/npp.2012.125 10.1016/j.mam.2005.12.003 10.1016/S0092‐8674(00)80782‐5 10.1038/tp.2013.123 10.1002/aur.62 10.1002/ajmg.b.30038 10.1186/gb-2014-15-3-r49 10.1038/ejhg.2012.243 10.1002/ajmg.b.32377 10.1007/s10803‐008‐0646‐7 10.1016/S1474‐4422(02)001606 10.1002/aur.188 10.1016/j.biopsych.2015.12.008 10.1177/0883073810384869 10.1016/j.neuropharm.2010.09.017 |
ContentType | Journal Article |
Copyright | 2017 ISDN Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved. Copyright Elsevier BV Nov 2017 |
Copyright_xml | – notice: 2017 ISDN – notice: Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier BV Nov 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 8FD C1K FR3 P64 7X8 5PM |
DOI | 10.1016/j.ijdevneu.2017.02.003 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Toxicology Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Technology Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1873-474X |
EndPage | 72 |
ExternalDocumentID | PMC5575980 28229923 10_1016_j_ijdevneu_2017_02_003 JDNJIJDEVNEU201702003 S0736574817300035 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: R01 MH093348 – fundername: NIMH NIH HHS grantid: R01 MH101043 – fundername: NIAAA NIH HHS grantid: P50 AA022538 – fundername: NIMH NIH HHS grantid: R24 MH068855 |
GroupedDBID | --- --K --M -~X .GJ .~1 0R~ 1B1 1OB 1OC 1RT 1~. 1~5 29J 33P 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAHHS AAIKJ AAKOC AALRI AANLZ AAOAW AAQFI AAQXK AAXLA AAXUO ABCQJ ABCUV ABFRF ABGSF ABIVO ABJNI ABMAC ABQWH ABXDB ABYKQ ACCFJ ACCZN ACDAQ ACGFO ACGFS ACGOF ACIUM ACIWK ACPOU ACPRK ACXQS ADBBV ADBTR ADEZE ADKYN ADMUD ADUVX ADZMN ADZOD AEEZP AEFWE AEIGN AEKER AENEX AEQDE AEUYR AFFPM AFRAH AFTJW AGHFR AGRDE AGUBO AGWIK AGYEJ AHBTC AHHHB AITUG AIURR AIWBW AJBDE AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS ALUQN AMFUW AMYDB ASPBG AVWKF AZFZN BFHJK BLXMC C45 CS3 DCZOG DOVZS DU5 EBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU G-2 G-Q GAKWD GBLVA HMQ HVGLF HZ~ IHE J1W LATKE LEEKS M2V M41 MEWTI MO0 MOBAO N9A O-L O9- OAUVE OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG RJQFR ROL RPZ SAMSI SCC SDF SDG SDP SES SEW SNS SSZ SUPJJ T5K TEORI UNMZH WUQ WXSBR ZGI ~G- AAHQN AAIPD AAMNL AAYCA ABWVN ACRPL ADNMO AFWVQ AITYG ALVPJ HGLYW AAYWO AAYXX ACVFH ADCNI AEUPX AEYWJ AFPUW AGHNM AGQPQ AGYGG AIGII CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 8FD C1K FR3 P64 7X8 5PM |
ID | FETCH-LOGICAL-c5173-444a3a48775891fd3f8d76378c8dc6ba1dd9236d2d6b16bfc37c607aa6eddd703 |
IEDL.DBID | .~1 |
ISSN | 0736-5748 1873-474X |
IngestDate | Thu Aug 21 14:01:53 EDT 2025 Fri Jul 11 06:17:39 EDT 2025 Sat Jul 26 02:15:09 EDT 2025 Mon Jul 21 05:52:01 EDT 2025 Thu Apr 24 22:58:07 EDT 2025 Tue Jul 01 01:06:45 EDT 2025 Wed Jan 22 16:34:04 EST 2025 Fri Feb 23 02:34:04 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | GABRB3 DNMT1 OXTR TET Chromatin Transcription 5caC ChIP ACTB 5hmC MECP2 5fC ASD RELN Repressors RETT BDNF-Tot CB MeDIP Hydroxymethylcytosine CON BDNF GAD1 IP qRT-PCR GAD2 5mC Gene expression hMeDIP BDNF-IV BDNF-IX REST Methylcytosine GABA GABA neuron FC GAPDH BA |
Language | English |
License | Copyright © 2017 ISDN. Published by Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5173-444a3a48775891fd3f8d76378c8dc6ba1dd9236d2d6b16bfc37c607aa6eddd703 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 28229923 |
PQID | 1968401432 |
PQPubID | 2045467 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5575980 proquest_miscellaneous_1871555323 proquest_journals_1968401432 pubmed_primary_28229923 crossref_primary_10_1016_j_ijdevneu_2017_02_003 crossref_citationtrail_10_1016_j_ijdevneu_2017_02_003 wiley_primary_10_1016_j_ijdevneu_2017_02_003_JDNJIJDEVNEU201702003 elsevier_sciencedirect_doi_10_1016_j_ijdevneu_2017_02_003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2017 |
PublicationDateYYYYMMDD | 2017-11-01 |
PublicationDate_xml | – month: 11 year: 2017 text: November 2017 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Oxford |
PublicationTitle | International journal of developmental neuroscience |
PublicationTitleAlternate | Int J Dev Neurosci |
PublicationYear | 2017 |
Publisher | Elsevier Ltd Elsevier BV |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier BV |
References | Yip, Soghomonian, Blatt (bib0275) 2007; 113 Colantuoni, Lipska, Ye, Hyde, Tao, Leek, Colantuoni, Elkahloun, Herman, Weinberger, Kleinman (bib0060) 2011; 478 Berg, Plioplys, Tuchman (bib0020) 2011; 26 Chen, Sharma, Costa, Costa, Grayson (bib0050) 2002; 30 Matrisciano, Tueting, Dalal, Kadriu, Grayson, Davis, Nicoletti, Guidotti (bib0205) 2013; 68 Represa, Ben-Ari (bib0240) 2005; 28 Ciernia, LaSalle (bib0055) 2016; 17 Chen, Dong, Grayson (bib0045) 2011; 60 Fatemi, Reutiman, Folsom, Rooney, Patel, Thuras (bib0100) 2010; 40 Mellén, Ayata, Dewell, Kriaucionis, Heintz (bib0215) 2012; 151 Fatemi, Reutiman, Folsom, Thuras (bib0095) 2009; 39 Ma, Whitehead, Menold, Martin, Ashley-Koch, Mei, Ritchie, Delong, Abramson, Wright, Cuccaro, Hussman, Gilbert, Pericak-Vance (bib0195) 2005; 77 Oblak, Rosene, Kemper, Bauman, Blatt (bib0225) 2011; 4 Button, Ioannidis, Mokrysz, Nosek, Flint, Robinson, Munafò (bib0030) 2013; 14 Ellis, Panitch, West, Arking (bib0080) 2016; 6 Yip, Soghomonian, Blatt (bib0280) 2009; 2 Ben-Ari (bib0015) 2015; 16 Wen, Li, Yan, Tan, Li, Zhao, Wang, Xie, Zhang, Song, Yu, Liu, Zhu, Li, Hou, Guo, Wu, He, Li, Tang, Qiao (bib0265) 2014; 15 Impagnatiello, Guidotti, Pesold, Dwivedi, Caruncho, Pisu, Uzunov, Smalheiser, Davis, Pandey, Pappas, Tueting, Sharma, Costa (bib0165) 1998; 95 Chang, Pauls, Lange, Sasanfar, Santangelo (bib0040) 2011; 156 Fatemi, Folsom, Reutiman, Thuras (bib0090) 2009; 8 McCauley, Olson, Delahanty, Amin, Nurmi, Organ, Jacobs, Folstein, Haines, Sutcliffe (bib0210) 2004; 131B James, Shpyleva, Melnyk, Pavliv, Pogribny (bib0170) 2014; 4 Richetto, Chesters, Cattaneo, Labouesse, Gutierrez, Wood, Luoni, Meyer, Vernon, Riva (bib0245) 2016 Labouesse, Dong, Grayson, Guidotti, Meyer (bib0185) 2015; 10 Piton, Jouan, Rochefort, Dobrzeniecka, Lachapelle, Dion, Gauthier, Rouleau (bib0235) 2013; 21 Gregory, Connelly, Towers, Johnson, Biscocho, Markunas, Lintas, Abramson, Wright, Ellis, Langford, Worley, Delong, Murphy, Cuccaro, Persico, Pericak-Vance (bib0135) 2009; 7 Grayson, Guidotti (bib0130) 2016; 8 Mariani, Coppola, Zhang, Abyzov, Provini, Tomasini, Amenduni, Szekely, Palejev, Wilson, Gerstein, Grigorenko, Chawarska, Pelphrey, Howe, Vaccarino (bib0200) 2015; 162 Kang, Barnes (bib0175) 2013; 43 Abasolo, Torrell, Roig, Moyano, Vilella, Martorell (bib0005) 2011; 45 Zhubi, Chen, Dong, Cook, Guidotti, Grayson (bib0295) 2014; 4 Ludwig, Zhang, Hastert, Meyer, Rausch, Herce, Müller, Lehmkuhl, Hellmann, Trummer, Storm, Leonhardt, Cardoso (bib0190) 2016 Ansel, Rosenzweig, Zisman, Melamed, Gesundheit (bib0010) 2017; 10 Voineagu, Wang, Johnston, Lowe, Tian, Horvath, Mill, Cantor, Blencowe, Geschwind (bib0260) 2011; 474 Casanova (bib0035) 2014; 83 Fleige, Pfaffl (bib0110) 2006; 27 Grayson, Guidotti (bib0125) 2013; 38 Zhao, Zhu, Yu, Qiu, Zhang, He, Zhang (bib0285) 2017; 54 Williams, Casanova (bib0270) 2011; 2 Tuchman, Rapin (bib0255) 2002; 1 Oblak, Gibbs, Blatt (bib0220) 2010; 114 Gabel, Kinde, Stroud, Gilbert, Harmin, Kastan, Hemberg, Ebert, Greenberg (bib0115) 2015; 522 Parikshak, Swarup, Belgard, Irimia, Ramaswami, Gandal, Hartl, Leppa, Ubieta, Huang, Lowe, Blencowe, Horvath, Geschwind (bib0230) 2016; 540 Guptill, Booker, Gibbs, Kemper, Bauman, Blatt (bib0150) 2007; 37 Zhubi, Cook, Guidotti, Grayson (bib0290) 2014; 115 Fatemi, Halt, Stary, Kanodia, Schulz, Realmuto (bib0085) 2002; 52 Gokoolparsadh, Sutton, Charamko, Green, Pardy, Voineagu (bib0120) 2016; 73 Trommsdorff, Gotthardt, Hiesberger, Shelton, Stockinger, Nimpf, Hammer, Richardson, Herz (bib0250) 1999; 97 Gupta, Ellis, Ashar, Moes, Bader, Zhan, West, Arking (bib0145) 2014; 5 D’Arcangelo, Miao, Chen, Soares, Morgan, Curran (bib0065) 1995; 374 Dong, Caruncho, Liu, Smalheiser, Grayson, Costa, Guidotti (bib0070) 2003; 100 Illingworth, Gruenewald-Schneider, De Sousa, Webb, Merusi, Kerr, James, Smith, Walker, Andrews, Bird (bib0160) 2015; 43 King, Walum, Inoue, Eyrich, Young (bib0180) 2015 Dong, Tueting, Matrisciano, Grayson, Guidotti (bib0075) 2016; 6 Guidotti, Auta, Davis, Di-Giorgi-Gerevini, Dwivedi, Grayson, Impagnatiello, Pandey, Pesold, Sharma, Uzunov, Costa (bib0140) 2000; 57 Blatt, Fitzgerald, Guptill, Booker, Kemper, Bauman (bib0025) 2001; 31 Fatemi, Reutiman, Folsom, Rustan, Rooney, Thuras (bib0105) 2014; 44 Harrison, Gamsiz, Berkowitz, Nagpal, Jerskey (bib0155) 2015; 168 2011; 478 2002; 52 2013; 21 2013; 68 2011; 60 2016; 540 2016; 73 1995; 374 2005; 28 2011; 156 2011; 474 2007; 37 2014; 5 2013; 14 2014; 4 2000; 57 2006; 27 2010; 114 2015; 43 2014; 15 1999; 97 2011; 26 1998; 95 2005; 77 2015; 162 2015; 16 2011; 2 2002; 30 2015; 522 2013; 43 2015; 168 2015; 10 2002; 1 2011; 4 2016; 17 2014; 83 2010; 40 2014; 44 2014; 115 2012; 151 2016; 6 2007; 113 2013; 38 2004; 131B 2017; 10 2017; 54 2009; 8 2009; 7 2016 2011; 45 2015 2009; 2 2003; 100 2016; 8 2001; 31 2009; 39 e_1_2_10_46_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 e_1_2_10_40_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_57_1 e_1_2_10_58_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 e_1_2_10_29_1 e_1_2_10_27_1 Williams E.L. (e_1_2_10_55_1) 2011; 2 e_1_2_10_48_1 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 Yip J. (e_1_2_10_56_1) 2007; 113 Fleige S. (e_1_2_10_23_1) 2006; 27 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_59_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 Richetto J. (e_1_2_10_50_1) 2016 Gokoolparsadh A. (e_1_2_10_25_1) 2016; 73 e_1_2_10_60_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_26_1 e_1_2_10_47_1 |
References_xml | – volume: 113 start-page: 559 year: 2007 end-page: 568 ident: bib0275 article-title: Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications publication-title: Acta Neuropathol. (Berl.) – volume: 374 start-page: 719 year: 1995 end-page: 723 ident: bib0065 article-title: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler publication-title: Nature – volume: 16 start-page: 498 year: 2015 end-page: 505 ident: bib0015 article-title: Is birth a critical period in the pathogenesis of autism spectrum disorders? publication-title: Nat. Rev. Neurosci. – volume: 8 start-page: 64 year: 2009 end-page: 69 ident: bib0090 article-title: Expression of GABA(B) receptors is altered in brains of subjects with autism publication-title: Cerebellum – volume: 37 start-page: 911 year: 2007 end-page: 920 ident: bib0150 article-title: [3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study publication-title: J. Autism Dev. Disord. – volume: 114 start-page: 1414 year: 2010 end-page: 1423 ident: bib0220 article-title: Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism publication-title: J. Neurochem. – volume: 6 start-page: e711 year: 2016 ident: bib0075 article-title: Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs publication-title: Transl. Psychiatry – volume: 131B start-page: 51 year: 2004 end-page: 59 ident: bib0210 article-title: A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet. – volume: 6 start-page: e817 year: 2016 ident: bib0080 article-title: Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia publication-title: Transl. Psychiatry – volume: 115 start-page: 203 year: 2014 end-page: 244 ident: bib0290 article-title: Epigenetic mechanisms in autism spectrum disorder publication-title: Int. Rev. Neurobiol. – volume: 83 start-page: 32 year: 2014 end-page: 38 ident: bib0035 article-title: Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasias publication-title: Med. Hypotheses – volume: 7 start-page: 62 year: 2009 ident: bib0135 article-title: Genomic and epigenetic evidence for oxytocin receptor deficiency in autism publication-title: BMC Med. – volume: 39 start-page: 223 year: 2009 end-page: 230 ident: bib0095 article-title: GABA(A) receptor downregulation in brains of subjects with autism publication-title: J. Autism Dev. Disord. – volume: 10 start-page: 1143 year: 2015 end-page: 1155 ident: bib0185 article-title: Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex publication-title: Epigenetics – volume: 4 start-page: 200 year: 2011 end-page: 211 ident: bib0225 article-title: Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism publication-title: Autism Res. – year: 2015 ident: bib0180 article-title: Variation in the oxytocin receptor gene predicts brain region-specific expression and social attachment publication-title: Biol. Psychiatry – volume: 30 start-page: 2930 year: 2002 end-page: 2939 ident: bib0050 article-title: On the epigenetic regulation of the human reelin promoter publication-title: Nucleic Acids Res. – volume: 57 start-page: 1061 year: 2000 end-page: 1069 ident: bib0140 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch. Gen. Psychiatry – volume: 10 start-page: 601 year: 2017 ident: bib0010 article-title: Variation in gene expression in autism spectrum disorders: an extensive review of transcriptomic studies publication-title: Front. Neurosci. – volume: 95 start-page: 15718 year: 1998 end-page: 15723 ident: bib0165 article-title: A decrease of reelin expression as a putative vulnerability factor in schizophrenia publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 54 start-page: 541 year: 2017 end-page: 550 ident: bib0285 article-title: Brain REST/NRSF is not only a silent repressor but also an active protector publication-title: Mol. Neurobiol. – volume: 44 start-page: 1833 year: 2014 end-page: 1845 ident: bib0105 article-title: Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism publication-title: J. Autism Dev. Disord. – volume: 43 start-page: 68 year: 2013 end-page: 79 ident: bib0175 article-title: A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA A receptors publication-title: J. Autism Dev. Disord. – volume: 474 start-page: 380 year: 2011 end-page: 384 ident: bib0260 article-title: Transcriptomic analysis of autistic brain reveals convergent molecular pathology publication-title: Nature – volume: 45 start-page: 1411 year: 2011 end-page: 1418 ident: bib0005 article-title: RT-qPCR study on post-mortem brain samples from patients with major psychiatric disorders: reference genes and specimen characteristics publication-title: J. Psychiatr. Res. – volume: 68 start-page: 184 year: 2013 end-page: 194 ident: bib0205 article-title: Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice publication-title: Neuropharmacology – volume: 28 start-page: 278 year: 2005 end-page: 283 ident: bib0240 article-title: Trophic actions of GABA on neuronal development publication-title: Trends Neurosci. – year: 2016 ident: bib0190 article-title: Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise publication-title: Nucleic Acids Res. – volume: 60 start-page: 1075 year: 2011 end-page: 1087 ident: bib0045 article-title: Analysis of the GAD1 promoter: trans-acting factors and DNA methylation converge on the 5′ untranslated region publication-title: Neuropharmacology – volume: 21 start-page: 749 year: 2013 end-page: 756 ident: bib0235 article-title: Analysis of the effects of rare variants on splicing identifies alterations in GABAA receptor genes in autism spectrum disorder individuals publication-title: Eur. J. Hum. Genet. – volume: 31 start-page: 537 year: 2001 end-page: 543 ident: bib0025 article-title: Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study publication-title: J. Autism Dev. Disord. – volume: 156 start-page: 233 year: 2011 end-page: 239 ident: bib0040 article-title: Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet. – volume: 38 start-page: 138 year: 2013 end-page: 166 ident: bib0125 article-title: The dynamics of DNA methylation in schizophrenia and related psychiatric disorders publication-title: Neuropsychopharmacology – volume: 14 start-page: 365 year: 2013 end-page: 376 ident: bib0030 article-title: Power failure: why small sample size undermines the reliability of neuroscience publication-title: Nat. Rev. Neurosci. – volume: 478 start-page: 519 year: 2011 end-page: 523 ident: bib0060 article-title: Temporal dynamics and genetic control of transcription in the human prefrontal cortex publication-title: Nature – volume: 4 start-page: e349 year: 2014 ident: bib0295 article-title: Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum publication-title: Transl. Psychiatry – volume: 100 start-page: 5479 year: 2003 end-page: 5484 ident: bib0070 article-title: A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 77 start-page: 377 year: 2005 end-page: 388 ident: bib0195 article-title: Identification of significant association and gene–gene interaction of GABA receptor subunit genes in autism publication-title: Am. J. Hum. Genet. – volume: 540 start-page: 423 year: 2016 end-page: 427 ident: bib0230 article-title: Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism publication-title: Nature – volume: 26 start-page: 540 year: 2011 end-page: 547 ident: bib0020 article-title: Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study publication-title: J. Child Neurol. – volume: 97 start-page: 689 year: 1999 end-page: 701 ident: bib0250 article-title: Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2 publication-title: Cell – volume: 15 start-page: R49 year: 2014 ident: bib0265 article-title: Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain publication-title: Genome Biol. – volume: 40 start-page: 743 year: 2010 end-page: 750 ident: bib0100 article-title: mRNA and protein levels for GABAA alpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism publication-title: J. Autism Dev. Disord. – volume: 17 start-page: 411 year: 2016 end-page: 423 ident: bib0055 article-title: The landscape of DNA methylation amid a perfect storm of autism aetiologies publication-title: Nat. Rev. Neurosci. – volume: 522 start-page: 89 year: 2015 end-page: 93 ident: bib0115 article-title: Disruption of DNA-methylation-dependent long gene repression in Rett syndrome publication-title: Nature – volume: 5 start-page: 5748 year: 2014 ident: bib0145 article-title: Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism publication-title: Nat. Commun. – volume: 151 start-page: 1417 year: 2012 end-page: 1430 ident: bib0215 article-title: MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system publication-title: Cell – year: 2016 ident: bib0245 article-title: Genome-wide transcriptional profiling and structural magnetic resonance imaging in the maternal immune activation model of neurodevelopmental disorders publication-title: Cereb. Cortex – volume: 73 start-page: 4517 year: 2016 end-page: 4520 ident: bib0120 article-title: Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies publication-title: Cell. Mol. Life Sci. – volume: 43 start-page: 732 year: 2015 end-page: 744 ident: bib0160 article-title: Inter-individual variability contrasts with regional homogeneity in the human brain DNA methylome publication-title: Nucleic Acids Res. – volume: 27 start-page: 126 year: 2006 end-page: 139 ident: bib0110 article-title: RNA integrity and the effect on the real-time qRT-PCR performance publication-title: Mol. Aspects Med. – volume: 8 start-page: 85 year: 2016 end-page: 104 ident: bib0130 article-title: Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder publication-title: Epigenomics – volume: 2 start-page: 50 year: 2009 end-page: 59 ident: bib0280 article-title: Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study publication-title: Autism Res. – volume: 52 start-page: 805 year: 2002 end-page: 810 ident: bib0085 article-title: Glutamic acid decarboxylase 65 and 67 publication-title: Biol. Psychiatry – volume: 168 start-page: 720 year: 2015 end-page: 729 ident: bib0155 article-title: Genetic variation in the oxytocin receptor gene is associated with a social phenotype in autism spectrum disorders publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet. – volume: 4 start-page: e460 year: 2014 ident: bib0170 article-title: Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum publication-title: Transl. Psychiatry – volume: 1 start-page: 352 year: 2002 end-page: 358 ident: bib0255 article-title: Epilepsy in autism publication-title: Lancet Neurol. – volume: 162 start-page: 375 year: 2015 end-page: 390 ident: bib0200 article-title: FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders publication-title: Cell – volume: 2 start-page: 106 year: 2011 end-page: 120 ident: bib0270 article-title: Above genetics: lessons from cerebral development in autism publication-title: Transl. Neurosci. – volume: 6 year: 2016 article-title: Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia publication-title: Transl. Psychiatry – volume: 522 start-page: 89 issue: (7554) year: 2015 end-page: 93 article-title: Disruption of DNA‐methylation‐dependent long gene repression in Rett syndrome publication-title: Nature – volume: 77 start-page: 377 issue: (3) year: 2005 end-page: 388 article-title: Identification of significant association and gene–gene interaction of GABA receptor subunit genes in autism publication-title: Am. J. Hum. Genet. – volume: 26 start-page: 540 year: 2011 end-page: 547 article-title: Risk and correlates of autism spectrum disorder in children with epilepsy: a community‐based study publication-title: J. Child Neurol. – volume: 15 start-page: R49 year: 2014 article-title: Whole‐genome analysis of 5‐hydroxymethylcytosine and 5‐methylcytosine at base resolution in the human brain publication-title: Genome Biol. – volume: 73 start-page: 4517 issue: (23) year: 2016 end-page: 4520 article-title: Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies publication-title: Cell. Mol. Life Sci. – volume: 44 start-page: 1833 issue: (8) year: 2014 end-page: 1845 article-title: Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism publication-title: J. Autism Dev. Disord. – volume: 21 start-page: 749 issue: (7) year: 2013 end-page: 756 article-title: Analysis of the effects of rare variants on splicing identifies alterations in GABAA receptor genes in autism spectrum disorder individuals publication-title: Eur. J. Hum. Genet. – volume: 97 start-page: 689 issue: (6) year: 1999 end-page: 701 article-title: Reeler/disabled‐like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2 publication-title: Cell – volume: 10 start-page: 601 year: 2017 article-title: Variation in gene expression in autism spectrum disorders: an extensive review of transcriptomic studies publication-title: Front. Neurosci. – volume: 113 start-page: 559 issue: (5) year: 2007 end-page: 568 article-title: Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications publication-title: Acta Neuropathol. (Berl.) – volume: 2 start-page: 106 issue: (2) year: 2011 end-page: 120 article-title: Above genetics: lessons from cerebral development in autism publication-title: Transl. Neurosci. – volume: 4 year: 2014 article-title: Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5‐hmC in autism spectrum disorder (ASD) cerebellum publication-title: Transl. Psychiatry – volume: 374 start-page: 719 year: 1995 end-page: 723 article-title: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler publication-title: Nature – volume: 95 start-page: 15718 issue: (26) year: 1998 end-page: 15723 article-title: A decrease of reelin expression as a putative vulnerability factor in schizophrenia publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 478 start-page: 519 year: 2011 end-page: 523 article-title: Temporal dynamics and genetic control of transcription in the human prefrontal cortex publication-title: Nature – volume: 45 start-page: 1411 issue: (11) year: 2011 end-page: 1418 article-title: RT‐qPCR study on post‐mortem brain samples from patients with major psychiatric disorders: reference genes and specimen characteristics publication-title: J. Psychiatr. Res. – volume: 27 start-page: 126 issue: (2–3) year: 2006 end-page: 139 article-title: RNA integrity and the effect on the real‐time qRT‐PCR performance publication-title: Mol. Aspects Med. – volume: 30 start-page: 2930 year: 2002 end-page: 2939 article-title: On the epigenetic regulation of the human reelin promoter publication-title: Nucleic Acids Res. – volume: 8 start-page: 64 issue: (1) year: 2009 end-page: 69 article-title: Expression of GABA(B) receptors is altered in brains of subjects with autism publication-title: Cerebellum – volume: 16 start-page: 498 issue: (8) year: 2015 end-page: 505 article-title: Is birth a critical period in the pathogenesis of autism spectrum disorders? publication-title: Nat. Rev. Neurosci. – volume: 57 start-page: 1061 issue: (11) year: 2000 end-page: 1069 article-title: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study publication-title: Arch. Gen. Psychiatry – volume: 31 start-page: 537 year: 2001 end-page: 543 article-title: Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study publication-title: J. Autism Dev. Disord. – volume: 83 start-page: 32 issue: (1) year: 2014 end-page: 38 article-title: Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasias publication-title: Med. Hypotheses – volume: 131B start-page: 51 issue: (1) year: 2004 end-page: 59 article-title: A linkage disequilibrium map of the 1‐Mb 15q12 GABA(A) receptor subunit cluster and association to autism publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet. – volume: 156 start-page: 233 issue: (2) year: 2011 end-page: 239 article-title: Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet. – volume: 43 start-page: 732 issue: (2) year: 2015 end-page: 744 article-title: Inter‐individual variability contrasts with regional homogeneity in the human brain DNA methylome publication-title: Nucleic Acids Res. – volume: 52 start-page: 805 issue: (8) year: 2002 end-page: 810 article-title: Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices publication-title: Biol. Psychiatry – volume: 28 start-page: 278 year: 2005 end-page: 283 article-title: Trophic actions of GABA on neuronal development publication-title: Trends Neurosci. – volume: 114 start-page: 1414 issue: (5) year: 2010 end-page: 1423 article-title: Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism publication-title: J. Neurochem. – volume: 4 year: 2014 article-title: Elevated 5‐hydroxymethylcytosine in the Engrailed‐2 (EN‐2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum publication-title: Transl. Psychiatry – year: 2016 article-title: Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise publication-title: Nucleic Acids Res. – volume: 5 start-page: 5748 year: 2014 article-title: Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity‐dependent genes in autism publication-title: Nat. Commun. – volume: 10 start-page: 1143 issue: (12) year: 2015 end-page: 1155 article-title: Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex publication-title: Epigenetics – volume: 1 start-page: 352 issue: (6) year: 2002 end-page: 358 article-title: Epilepsy in autism publication-title: Lancet Neurol. – volume: 39 start-page: 223 issue: (2) year: 2009 end-page: 230 article-title: GABA(A) receptor downregulation in brains of subjects with autism publication-title: J. Autism Dev. Disord. – volume: 43 start-page: 68 issue: (1) year: 2013 end-page: 79 article-title: A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA A receptors publication-title: J. Autism Dev. Disord. – volume: 6 year: 2016 article-title: Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs publication-title: Transl. Psychiatry – volume: 14 start-page: 365 issue: (5) year: 2013 end-page: 376 article-title: Power failure: why small sample size undermines the reliability of neuroscience publication-title: Nat. Rev. Neurosci. – year: 2015 article-title: Variation in the oxytocin receptor gene predicts brain region‐specific expression and social attachment publication-title: Biol. Psychiatry – volume: 68 start-page: 184 year: 2013 end-page: 194 article-title: Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia‐like phenotype induced by prenatal stress in mice publication-title: Neuropharmacology – volume: 151 start-page: 1417 issue: (7) year: 2012 end-page: 1430 article-title: MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system publication-title: Cell – volume: 60 start-page: 1075 issue: (7–8) year: 2011 end-page: 1087 article-title: Analysis of the GAD1 promoter: trans‐acting factors and DNA methylation converge on the 5′ untranslated region publication-title: Neuropharmacology – volume: 17 start-page: 411 issue: (7) year: 2016 end-page: 423 article-title: The landscape of DNA methylation amid a perfect storm of autism aetiologies publication-title: Nat. Rev. Neurosci. – volume: 540 start-page: 423 issue: (7633) year: 2016 end-page: 427 article-title: Genome‐wide changes in lncRNA, splicing, and regional gene expression patterns in autism publication-title: Nature – volume: 8 start-page: 85 issue: (1) year: 2016 end-page: 104 article-title: Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder publication-title: Epigenomics – volume: 115 start-page: 203 year: 2014 end-page: 244 article-title: Epigenetic mechanisms in autism spectrum disorder publication-title: Int. Rev. Neurobiol. – volume: 7 start-page: 62 year: 2009 article-title: Genomic and epigenetic evidence for oxytocin receptor deficiency in autism publication-title: BMC Med. – volume: 37 start-page: 911 issue: (5) year: 2007 end-page: 920 article-title: [3H]‐flunitrazepam‐labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study publication-title: J. Autism Dev. Disord. – volume: 474 start-page: 380 issue: (7351) year: 2011 end-page: 384 article-title: Transcriptomic analysis of autistic brain reveals convergent molecular pathology publication-title: Nature – volume: 100 start-page: 5479 year: 2003 end-page: 5484 article-title: A reelin‐integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 38 start-page: 138 issue: (1) year: 2013 end-page: 166 article-title: The dynamics of DNA methylation in schizophrenia and related psychiatric disorders publication-title: Neuropsychopharmacology – volume: 2 start-page: 50 issue: (1) year: 2009 end-page: 59 article-title: Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study publication-title: Autism Res. – volume: 168 start-page: 720 issue: (8) year: 2015 end-page: 729 article-title: Genetic variation in the oxytocin receptor gene is associated with a social phenotype in autism spectrum disorders publication-title: Am. J. Med. Genet. B: Neuropsychiatr. Genet. – volume: 162 start-page: 375 issue: (2) year: 2015 end-page: 390 article-title: FOXG1‐dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders publication-title: Cell – year: 2016 article-title: Genome‐wide transcriptional profiling and structural magnetic resonance imaging in the maternal immune activation model of neurodevelopmental disorders publication-title: Cereb. Cortex – volume: 4 start-page: 200 issue: (3) year: 2011 end-page: 211 article-title: Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism publication-title: Autism Res. – volume: 54 start-page: 541 issue: (1) year: 2017 end-page: 550 article-title: Brain REST/NRSF is not only a silent repressor but also an active protector publication-title: Mol. Neurobiol. – volume: 40 start-page: 743 issue: (6) year: 2010 end-page: 750 article-title: mRNA and protein levels for GABAA alpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism publication-title: J. Autism Dev. Disord. – ident: e_1_2_10_18_1 doi: 10.1016/S0006‐3223(02)01430‐0 – ident: e_1_2_10_7_1 doi: 10.1038/nrn3475 – ident: e_1_2_10_59_1 doi: 10.1016/B978‐0‐12‐801311‐3.00006‐8 – ident: e_1_2_10_2_1 doi: 10.1016/j.jpsychires.2011.06.001 – ident: e_1_2_10_11_1 doi: 10.1093/nar/gkf401 – ident: e_1_2_10_28_1 doi: 10.1186/1741‐7015‐7‐62 – ident: e_1_2_10_33_1 doi: 10.1093/nar/gku1305 – ident: e_1_2_10_38_1 doi: 10.1080/15592294.2015.1114202 – ident: e_1_2_10_44_1 doi: 10.1016/j.cell.2012.11.022 – ident: e_1_2_10_39_1 doi: 10.1093/nar/gkw1197 – ident: e_1_2_10_24_1 doi: 10.1038/nature14319 – ident: e_1_2_10_31_1 doi: 10.1007/s10803‐006‐0226‐7 – ident: e_1_2_10_29_1 doi: 10.1001/archpsyc.57.11.1061 – ident: e_1_2_10_4_1 doi: 10.1038/nrn3956 – ident: e_1_2_10_45_1 doi: 10.1111/j.1471‐4159.2010.06858.x – ident: e_1_2_10_13_1 doi: 10.1038/nature10524 – ident: e_1_2_10_49_1 doi: 10.1016/j.tins.2005.03.010 – ident: e_1_2_10_17_1 doi: 10.1038/tp.2016.87 – ident: e_1_2_10_19_1 doi: 10.1007/s12311‐008‐0075‐3 – ident: e_1_2_10_35_1 doi: 10.1038/tp.2014.87 – ident: e_1_2_10_36_1 doi: 10.1007/s10803‐012‐1543‐7 – ident: e_1_2_10_6_1 doi: 10.1023/A:1013238809666 – ident: e_1_2_10_58_1 doi: 10.1007/s12035‐015‐9658‐4 – ident: e_1_2_10_3_1 doi: 10.3389/fnins.2016.00601 – volume: 113 start-page: 559 issue: 5 year: 2007 ident: e_1_2_10_56_1 article-title: Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications publication-title: Acta Neuropathol. (Berl.) doi: 10.1007/s00401-006-0176-3 – volume: 73 start-page: 4517 issue: 23 year: 2016 ident: e_1_2_10_25_1 article-title: Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-016-2304-0 – ident: e_1_2_10_53_1 doi: 10.1038/nature10110 – ident: e_1_2_10_47_1 doi: 10.1038/nature20612 – ident: e_1_2_10_41_1 doi: 10.1016/j.cell.2015.06.034 – volume: 2 start-page: 106 issue: 2 year: 2011 ident: e_1_2_10_55_1 article-title: Above genetics: lessons from cerebral development in autism publication-title: Transl. Neurosci. doi: 10.2478/s13380-011-0016-3 – ident: e_1_2_10_8_1 doi: 10.1016/j.mehy.2014.04.014 – ident: e_1_2_10_22_1 doi: 10.1007/s10803‐014‐2078‐x – ident: e_1_2_10_16_1 doi: 10.1038/tp.2015.191 – ident: e_1_2_10_15_1 doi: 10.1073/pnas.1031602100 – ident: e_1_2_10_14_1 doi: 10.1038/374719a0 – year: 2016 ident: e_1_2_10_50_1 article-title: Genome‐wide transcriptional profiling and structural magnetic resonance imaging in the maternal immune activation model of neurodevelopmental disorders publication-title: Cereb. Cortex – ident: e_1_2_10_12_1 doi: 10.1038/nrn.2016.41 – ident: e_1_2_10_27_1 doi: 10.2217/epi.15.92 – ident: e_1_2_10_42_1 doi: 10.1016/j.neuropharm.2012.04.013 – ident: e_1_2_10_30_1 doi: 10.1038/ncomms6748 – ident: e_1_2_10_34_1 doi: 10.1073/pnas.95.26.15718 – ident: e_1_2_10_40_1 doi: 10.1086/433195 – ident: e_1_2_10_9_1 doi: 10.1002/ajmg.b.31148 – ident: e_1_2_10_21_1 doi: 10.1007/s10803‐009‐0924‐z – ident: e_1_2_10_26_1 doi: 10.1038/npp.2012.125 – volume: 27 start-page: 126 issue: 2 year: 2006 ident: e_1_2_10_23_1 article-title: RNA integrity and the effect on the real‐time qRT‐PCR performance publication-title: Mol. Aspects Med. doi: 10.1016/j.mam.2005.12.003 – ident: e_1_2_10_51_1 doi: 10.1016/S0092‐8674(00)80782‐5 – ident: e_1_2_10_60_1 doi: 10.1038/tp.2013.123 – ident: e_1_2_10_57_1 doi: 10.1002/aur.62 – ident: e_1_2_10_43_1 doi: 10.1002/ajmg.b.30038 – ident: e_1_2_10_54_1 doi: 10.1186/gb-2014-15-3-r49 – ident: e_1_2_10_48_1 doi: 10.1038/ejhg.2012.243 – ident: e_1_2_10_32_1 doi: 10.1002/ajmg.b.32377 – ident: e_1_2_10_20_1 doi: 10.1007/s10803‐008‐0646‐7 – ident: e_1_2_10_52_1 doi: 10.1016/S1474‐4422(02)001606 – ident: e_1_2_10_46_1 doi: 10.1002/aur.188 – ident: e_1_2_10_37_1 doi: 10.1016/j.biopsych.2015.12.008 – ident: e_1_2_10_5_1 doi: 10.1177/0883073810384869 – ident: e_1_2_10_10_1 doi: 10.1016/j.neuropharm.2010.09.017 |
SSID | ssj0005504 |
Score | 2.3964686 |
Snippet | •The RELN and GAD1 mRNA levels were reduced in ASD PFC.•TET 1, 2, and 3 mRNAs were increased in ASD PFC.•There was increased DNMT1 and MECP2 promoter... Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously... Both Reelin (RELN) and glutamate decarboxylase 67 (GAD1) have been implicated in the pathophysiology of Autism Spectrum Disorders (ASD). We have previously... |
SourceID | pubmedcentral proquest pubmed crossref wiley elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 63 |
SubjectTerms | 5-Methylcytosine - analogs & derivatives 5-Methylcytosine - pharmacology Adolescent Adult Analysis of Variance Autism Autism Spectrum Disorder - genetics Autism Spectrum Disorder - pathology Brain Cell Adhesion Molecules, Neuronal - genetics Cell Adhesion Molecules, Neuronal - metabolism Chromatin Chromatin Immunoprecipitation Cohort Studies Cortex (frontal) Deoxyribonucleic acid DNA DNA (Cytosine-5-)-Methyltransferase 1 - metabolism DNMT1 protein Epigenesis, Genetic - physiology Epigenetics Extracellular Matrix Proteins - genetics Extracellular Matrix Proteins - metabolism Female Frontal Lobe - metabolism GABA neuron Gene expression Gene regulation Genes Glutamate decarboxylase Glutamate Decarboxylase - genetics Glutamate Decarboxylase - metabolism Humans Hydroxymethylcytosine Immunoprecipitation Male MeCP2 protein Methyl-CpG binding protein Methyl-CpG-Binding Protein 2 - metabolism Methylcytosine mRNA Nerve Tissue Proteins - genetics Nerve Tissue Proteins - metabolism Neurons Promoter Regions, Genetic Promoters Protein Binding - genetics Proteins Reelin Protein Repressors Ribonucleic acid RNA RNA, Messenger - metabolism Serine Endopeptidases - genetics Serine Endopeptidases - metabolism Transcription Translocation Young Adult γ-Aminobutyric acid |
Title | Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects |
URI | https://dx.doi.org/10.1016/j.ijdevneu.2017.02.003 https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.ijdevneu.2017.02.003 https://www.ncbi.nlm.nih.gov/pubmed/28229923 https://www.proquest.com/docview/1968401432 https://www.proquest.com/docview/1871555323 https://pubmed.ncbi.nlm.nih.gov/PMC5575980 |
Volume | 62 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF5VPXFBQHkEWrRICLUHN37swz6GxKFEkAMlqLfVviwcNU7UkAou_HZm_IgSVahIHO3dtayZ2ZlZ-5tvCHkrMsi6Ic4HQqcmYM7HgTEyCgod-RCcIYQsLHD-PBUXMza54lcHZNjVwiCssvX9jU-vvXV7p99Ks78qy_4lGKfgkqURUq6HCRaaMybRys9_78A8eN1CECcHOHunSnh-Xs6dv638BiFesuHuTP4WoO4moHdxlLv5bR2gxo_IwzazpIPm5R-TA189IUeDCk7Vi1_0Ha2xnvVH9CNyna-QhRMLGOlN040e9EOXBf2Sf5pSXTn6YTCKaFlRSBBpgSwH8GyLyNyf9HQ8PMO5Gox2vaB1sebNZkFdy-RJTweXozO63hj8yLN-Smbj_OvwImj7LgSWgzADxphONJxkJLYcLFxSpA7ckExt6qwwOnIO0kLhYidMJExhE2lFKLUW3jkHLuQZOayWlX9BaCyltUYUSRobhnAxZlPpwyQ1WWE1L3qEd8JWtiUlx94Y16pDn81VpySFSlJhjHSmPdLfrls1tBz3rsg6Xao9A1MQO-5de9wpX7VbfK3AdcHhGNLNuEfebIdhc-IfF1355QbmwHGUc57E8Ijnja1sXxfxu1mGI3LPirYTkPh7f6Qqv9cE4By7qqZhj7yv7e0fJaAmo-nk42SUf5vmM7wfIjDx5X_I5RV5gFdNaeYxOQRb8yeQo_0wr-tN-AeuXjiK |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF6VcoALAgo0UGCREGoPbvzaXfsYEoc0pD7QBvW22octHDVO1BAEF347M35EiSpUJK7e2ZW1Mzsza3_zDSHveQxZN8R5h6tIO6HNfEdr4Tm58jIXnCGELCxwPk_5aBqOr9jVHum3tTAIq2x8f-3TK2_dPOk2u9ldFkX3AoyTMxFGHlKuuwG7R-6HcHyxjcHp7y2cB6t6CKK0g-JbZcKz02Jmsx9ltkaMl6jJO4O_RajbGehtIOV2gltFqOFj8qhJLWmvfvsnZC8rn5KDXgnX6vkv-oFWYM_qK_oBuU6WSMOJFYz0pm5HDwqii5x-SSYpVaWln3oDjxYlhQyR5khzAGsbhOb-pMfD_gnKKrDa1ZxW1Zo36zm1DZUnPe5dDE7oaq3xK8_qGZkOk8v-yGkaLziGwW46YRiqQMFVRmDPwdwGeWTBD4nIRNZwrTxrIS_k1rdce1znJhCGu0IpnllrwYc8J_vloswOCfWFMEbzHPSiQ8SLhSYSmRtEOs6NYnmHsHazpWlYybE5xrVs4Wcz2SpJopKk6yOfaYd0N_OWNS_HnTPiVpdyx8IkBI875x61ypfNGV9J8F1wO4Z80--Qd5thOJ34y0WV2WINMnAfZYwFPizxoraVzesigDeOcUTsWNFGAJm_d0fK4lvFAM6wrWrkdsjHyt7-cQfkeJCOz8aD5GuaTPG5i8jEl_-xL2_Jg9Hl-UROztLPr8hDHKnrNI_IPthd9hoStu_6TXUg_wBNTzum |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epigenetic+regulation+of+RELN+and+GAD1+in+the+frontal+cortex+%28FC%29+of+autism+spectrum+disorder+%28ASD%29+subjects&rft.jtitle=International+journal+of+developmental+neuroscience&rft.au=Zhubi%2C+A&rft.au=Chen%2C+Y&rft.au=Guidotti%2C+A&rft.au=Grayson%2C+DR&rft.date=2017-11-01&rft.issn=0736-5748&rft.eissn=1873-474X&rft.volume=62&rft.spage=63&rft.epage=72&rft_id=info:doi/10.1016%2Fj.ijdevneu.2017.02.003&rft_id=info%3Apmid%2F28229923&rft.externalDocID=PMC5575980 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0736-5748&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0736-5748&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0736-5748&client=summon |